Dr. Joseph Lochinvar Dinglasan Jr., MD

Dr. Dinglasan practices at Adventist Health White Memorial in Los Angeles, California, part of Adventist Health.

Dr. Dinglasan's NPI, 1457515272, was assigned on July 10, 2008. Dr. Dinglasan graduated from University of California, Irvine, California College of Medicine in 2008. Dr. Dinglasan holds California license A109801.

Dr. Dinglasan's primary practice is Adventist Health White Memorial, at 1720 Cesar E Chavez Avenue, Los Angeles, CA 90033 in Los Angeles County. The practice phone is (323) 268-5000.

Dr. Dinglasan's primary practice is Adventist Health White Memorial in Los Angeles, California, part of Adventist Health. Dr. Dinglasan is also affiliated with Providence Mission Hospital. The medical group on file is Vituity. Dmand AI also links Dr. Dinglasan to 3 more hospitals, 9 medical groups, 3 physician offices, 1 group practice or clinic, 1 home health agency and 1 ambulatory surgery center, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Dinglasan practices, 11 sites in all. Vendor and product names are available with a free account.

Emergency medicine is Dr. Dinglasan's primary specialty in the NPI Registry, under taxonomy code 207P00000X. Dr. Dinglasan is licensed in California.

CMS data shows 514 Medicare services from Dr. Dinglasan across 4 procedure codes in 2024, for 303 Medicare patients. Medicare paid $45,352 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 303 Medicare patients who saw Dr. Dinglasan in 2024. The largest group is 75 to 84, with 95 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 46% are also on Medicaid. Their average risk score is 2.45, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Dinglasan's median patient age at 36, with 60% women.

In 2024, Dr. Dinglasan wrote 281 Medicare Part D claims for 158 patients. 90% of them were for generic drugs. CMS names the drug for 143 of them, across 8 drugs with 11 or more claims each, at $757 in total drug cost. In 2023, CMS named 144 claims across 4 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 92 out of 100 for Dr. Dinglasan for performance year 2024, reported as part of a group. Dr. Dinglasan accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 1 paper to Dr. Dinglasan in 2018. Dr. Dinglasan's most frequent co-author is Amanda A. Balmages, DO, MPH.

CMS Open Payments shows 4 general payments to Dr. Dinglasan from 1 drug or device company in 2023. Food and beverage make up the largest share, 100% of the total. Merz North America, Inc. paid the most, $426.

Dr. Dinglasan graduated from University of California, Irvine, California College of Medicine in 2008.